Saudi Arabia · Delayed Price · Currency is SAR Saudi Basic Industries Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw revenue decline 6% sequentially to $7B, but adjusted EBITDA rose 25% to $1B as cost discipline and higher prices offset lower volumes. Portfolio optimization, innovation, and strategic projects advanced, with management guiding for continued price strength and disciplined capital allocation.
Fiscal Year 2025
-
Q3 2025 saw stable demand, a 3% sequential revenue decline to $9.2B, and a 45% rise in adjusted net income. Transformation and cost optimization drove $300M in value, while major projects advanced on schedule. Outlook remains cautious amid persistent overcapacity.
-
Q2 2025 saw a 3% revenue increase to $9.5B, with adjusted EBITDA up 40% sequentially. Portfolio optimization led to a $1.1B net loss due to Teesside closure, but transformation and digital initiatives are on track, and capital investment for 2025 is set at $3–3.5B.
-
Q1 2025 delivered stable revenue of $9.2 billion, with EBITDA up 7% excluding $300 million in restructuring costs. Strategic cost-saving and portfolio optimization initiatives are underway, while major growth and sustainability projects progress on schedule.
Fiscal Year 2024
-
Revenue reached $37.3B, down 1% year-over-year, while EBITDA rose 2% to $5.2B and net income improved by $1.1B, aided by one-time gains. Strategic divestments, new projects, and cost initiatives supported resilience amid persistent industry overcapacity.
-
Q3 2024 saw revenue rise 3% sequentially to $9.8B, with stable EBITDA and a sharp year-over-year net income increase, driven by portfolio optimization and resilient sales volumes. CapEx guidance was cut to $3.3–$3.9B, and further asset rationalization in Europe is ongoing.
-
Q2 2024 saw a 9% revenue increase and 26% EBITDA growth, driven by higher sales volumes and portfolio optimization. Key milestones included the Hadeed divestment, sustainability awards, and strong progress on major projects, with stable outlook and disciplined CapEx.